As coronavirus cases continue to rise in the UK, we look at how cancer clinical trials have been affected by the pandemic.
The National Lung Matrix Trial – a £25 million collaboration with pharmaceutical companies and the NHS – has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.
NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.
Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results.
The first clinical trial testing Owlstone’s Breath Biopsy® technology on a range of cancer types is now open.
Researchers are trying to diagnose lung cancer early through screening, and studying if the benefits of early detection outweigh the harms.
Trial finds prostate radiotherapy plus standard treatment improves survival for some men whose prostate cancer has spread, which could help thousands in the UK.
Guest author, Dr Rosanna Jackson, outlines what scientists are doing to make treatment for one type of childhood leukaemia kinder.
We look at how research could help to adapt and improve treatment for older patients, including inclusive clinical trials and pre-habilitation.